Background And Purpose: Case series indicating cerebrovascular disorders in coronavirus disease 2019 (COVID-19) have been published. Comprehensive workups, including clinical characteristics, laboratory, electroencephalography, neuroimaging, and cerebrospinal fluid findings, are needed to understand the mechanisms.
Methods: We evaluated 32 consecutive critically ill patients with COVID-19 treated at a tertiary care center from March 9 to April 3, 2020, for concomitant severe central nervous system involvement.
Objective: To assess and reduce delays in coronary thrombolysis in patients with acute myocardial infarction.
Design: Prospective, descriptive study using statistical process control.
Setting: Interdisciplinary intensive care unit of a 300-bed community hospital.